RxDoctor Payments Data

Joshua Johnson

Physician Assistant · Loma Linda, CANPI 1558885293

Payments from drug & device makers

$1,478in general payments, 2019–2025

Across 79 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$581
  • Alkermes, Inc.$369
  • AbbVie$158
  • Otsuka America Pharmaceutical, Inc.$82
  • Johnson & Johnson$81
  • Vanda Pharmaceuticals Inc.$57
  • plus $150 from 5 others

What the payments were for

  • Food & beverage$1,477100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,478 in reported general payments places this provider in the 75th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$2,955
Medicare patients
14
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UzedyRisperidone17$55,047
Invega SustennaPaliperidone Palmitate17$40,820
OzempicSemaglutide32$32,626
CaplytaLumateperone Tosylate18$28,633
JardianceEmpagliflozin22$13,090
TrintellixVortioxetine Hydrobromide13$6,660
Lurasidone Hcl14$5,795
BrilintaTicagrelor12$5,187
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen207$4,979
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen25$3,034
Divalproex Sodium28$2,488
Gabapentin118$2,035
Celecoxib13$1,708
Divalproex Sodium ErDivalproex Sodium14$1,564
Olanzapine19$1,367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Uzedy$31$55,04717 claims
Johnson & JohnsonInvega Sustenna$81$40,82017 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$581$28,63318 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$18$6,66013 claims
Lilly USA, LLCOlanzapine$52$1,36719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Loma Linda

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →